000			01803 a2200481 4500
005			20250513212733.0
264		0	_c20000818
008			200008s 0 0 eng d
022			_a0306-4522
024	7		_a10.1016/s0306-4522(00)00130-5 _2doi
040			_aNLM _beng _cNLM
100	1		_aQuik, M
245	0	0	_aExpression of D(3) receptor messenger RNA and binding sites in monkey striatum and substantia nigra after nigrostriatal degeneration: effect of levodopa treatment. _h[electronic resource]
260			_bNeuroscience _c2000
300			_a263-73 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_a1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine _xadverse effects
650	0	4	_aAnimals
650	0	4	_aBehavior, Animal _xdrug effects
650	0	4	_aBinding Sites _xdrug effects
650	0	4	_aCarrier Proteins _xdrug effects
650	0	4	_aCaudate Nucleus _xdrug effects
650	0	4	_aDopamine Plasma Membrane Transport Proteins
650	0	4	_aFemale
650	0	4	_aLevodopa _xpharmacology
650	0	4	_aMale
650	0	4	_aMembrane Glycoproteins
650	0	4	_aMembrane Transport Proteins
650	0	4	_aNeostriatum _xdrug effects
650	0	4	_aNerve Tissue Proteins
650	0	4	_aParkinsonian Disorders _xdrug therapy
650	0	4	_aRNA, Messenger _xmetabolism
650	0	4	_aReceptors, Dopamine D2 _xagonists
650	0	4	_aReceptors, Dopamine D3
650	0	4	_aSaimiri
650	0	4	_aSubstantia Nigra _xdrug effects
700	1		_aPolice, S
700	1		_aHe, L
700	1		_aDi Monte, D A
700	1		_aLangston, J W
773	0		_tNeuroscience _gvol. 98 _gno. 2 _gp. 263-73
856	4	0	_uhttps://doi.org/10.1016/s0306-4522(00)00130-5 _zAvailable from publisher's website
999			_c10805807 _d10805807